Temporal trends of blood eosinophilia in severe uncontrolled CRSwNP treated with dupilumab: a real-life study
European Archives of Oto-Rhino-Laryngology · 2024-05 · 281 (5) · 2429-2440
DOI: 10.1007/s00405-023-08417-8 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Archives of Oto-Rhino-Laryngology, online erschienen am 29.12.2023. Verfasst von Eugenio De Corso und 12 weiteren Autor:innen. Beteiligte Einrichtung: Unit of Otorhinolaryngology and Head-Neck Surgery, "A. Gemelli" Hospital Foundation IRCCS, 00168, Rome, Italy. Hauptthemen laut MEDLINE: Nasal Polyps, Sinusitis, Rhinitis, Eosinophilia. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 46 Literaturangaben.
Abstract (Originalsprache)
PURPOSE: Induced eosinophilia is commonly related to dupilumab treatment. We analysed the temporal trends of blood eosinophilia in patients with severe uncontrolled CRSwNP during the first year of treatment with dupilumab in real-life setting to evaluate its correlation with outcomes of response and adverse events (AEs). METHODS: Seventy-four patients with severe uncontrolled CRSwNP treated with dupilumab at our institution were enrolled. At each visit, we evaluated AEC, outcomes of response to treatment and AEs. RESULTS: A significant increase in AEC was observed since the first month with a peak at 3 months; at 12 months, the values returned comparable to those at baseline. A ≥ 50% increase of the baseline AEC with a value greater than 500 cells/mm3 was documented in 38/74 patients (Group A) regardless of the time of observation, whereas in 36/74 patients (Group B), no changes were observed. Analysing the blood eosinophilia trend over time in group A, we observed a temporary eosinophilia with early onset (within 6 months), persistent eosinophilia with early onset, and eosinophilia with late onset. No differences in terms of outcomes of response to treatment or AEs were found between Group A and Group B, or between patients who developed an AEC ≥ 1500 cells/mm3 or not. CONCLUSION: In our series, we observed that an increase in AEC with different temporal trends may be observed in CRSwNP patients during the first year of treatment with dupilumab. In our series, eosinophilia is not correlated with a negative outcome of response to treatment or a risk of AEs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Unit of Otorhinolaryngology and Head-Neck Surgery, "A. Gemelli" Hospital Foundation IRCCS, 00168, Rome, Italy.
- Department of Head-Neck and Sensory Organs, Catholic University of Sacred Heart, 00168, Rome, Italy. claudio_montuori@libero.it.
- Unit of Chemistry, Biochemistry and Molecular Biology, "A. Gemelli" Hospital Foundation IRCCS, 00168, Rome, Italy.
- Department of Basic Biotechnological Sciences, Intensive Care and Perioperative Clinics, Catholic University of Sacred Heart, 00168, Rome, Italy.
- ENT Department, Rivoli Hospital, ASL TORINO 3, 10098, Turin, Italy.
- Department of Head-Neck and Sensory Organs, Catholic University of Sacred Heart, 00168, Rome, Italy.
Zitieren
APA
De Corso, E., Montuori, C., Baroni, S., Mastrapasqua, R. F., Porru, D. P., D'Auria, L. M., D'Agostino, G., Penazzi, D., De Maio, G., Onori, M. E., Sarlo, F., Corbo', M., & Galli, J. (2024). Temporal trends of blood eosinophilia in severe uncontrolled CRSwNP treated with dupilumab: a real-life study. European Archives of Oto-Rhino-Laryngology, 281(5), 2429-2440. https://doi.org/10.1007/s00405-023-08417-8
Vancouver
De Corso E, Montuori C, Baroni S, Mastrapasqua RF, Porru DP, D'Auria LM, et al. Temporal trends of blood eosinophilia in severe uncontrolled CRSwNP treated with dupilumab: a real-life study. European Archives of Oto-Rhino-Laryngology. 2024;281(5):2429-2440. doi:10.1007/s00405-023-08417-8
BibTeX
@article{DeCorso2024,
author = {De Corso, Eugenio and Montuori, Claudio and Baroni, Silvia and Mastrapasqua, Rodolfo F and Porru, Davide P and D'Auria, Leandro M and D'Agostino, Giuseppe and Penazzi, Daniele and De Maio, Gabriele and Onori, Maria E and Sarlo, Francesca and Corbo', Marco and Galli, Jacopo},
title = {Temporal trends of blood eosinophilia in severe uncontrolled CRSwNP treated with dupilumab: a real-life study},
journal = {European Archives of Oto-Rhino-Laryngology},
year = {2024},
volume = {281},
number = {5},
pages = {2429--2440},
doi = {10.1007/s00405-023-08417-8}
}
EUVIMED